After confirming ADAM10 downregulation by western blot analysis (Figure 6D and 6E), blots were reprobed with c-Myc, cyclin D1 as well as CD44, all of which showed reduction in ADAM10 depleted cells, indicating that ADAM10 regulates catenin-dependent intracellular signaling in the cancer cells. This evidence concerns the gene MYC and cancer.